Global trends in the fields of Plastic, Reconstructive, ENT, and Oral Maxillofacial (OMF) surgery highlight the rising demand for advanced technologies and techniques, particularly in the use of biologics. The global allograft market is projected to grow significantly, with estimates placing it at over $5 billion by 2027, driven by a surge in reconstructive procedures and innovations in tissue engineering. The allograft industry continues to grow, with 2.2 million transplants annually worldwide.
An estimated 2 million dental grafting procedures are performed each year, with demand driven by the increase in dental implant procedures, periodontal disease management, and a focus on oral reconstruction.
Approximately 850,000 surgical rhinoplasty procedures are performed globally each year, underscoring its popularity as one of the top facial cosmetic surgeries worldwide. Meanwhile, fat grafting, valued at $1.3 billion, is increasingly popular for natural augmentation in facial and body contouring. Around 23 million cosmetic surgeries are performed each year, with breast reconstruction and augmentation accounting for 2.7 million cases, addressing both reconstructive and enhancement needs.
Biotechnology advancements are reshaping surgical methods, enabling customised solutions with enhanced safety and efficacy. This diverse landscape reflects the industry’s steady growth and the requirements for the industry to continuously evolve to meet patient needs.
